{Reference Type}: Journal Article
{Title}: What´s new in intraabdominal candidiasis in critically ill patients, a review.
{Author}: Lagunes L;Rey-Pérez A;
{Journal}: Hosp Pract (1995)
{Volume}: 47
{Issue}: 4
{Year}: Oct 2019
暂无{DOI}: 10.1080/21548331.2019.1677032
{Abstract}: A high prevalence of invasive candidiasis has been reported in recent years. Patients admitted to an intensive care unit are at the highest risk for invasive candidiasis, mostly due to the severity of their disease, immune-suppressive states, prolonged length of stay, broad-spectrum antibiotics, septic shock, and Candida colonization. Intraabdominal candidiasis comprises a range of clinical manifestations, from just the suspicion based on clinical scenario to fever, leukocytosis, increase in biomarkers to the isolation of the responsible microorganism. In critically ill patients with IAC prompt treatment and adequate source control remains the ultimate goal.